DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20210579

Melasma and sun exposure: a clinicoepidemiological study

Suman B. Parsam, Swetha Tallam

Abstract


Background: Melasma is a chronic hyper pigmentary disorder mainly affecting females. It presents over the sun exposed areas of face. Various factors implicated in the etiology are sun exposure, pregnancy, OCPs, hormonal therapy, thyroid disorders, cosmetic use etc. The major causative factors are genetic predisposition and sun exposure. This study was aimed at studying the relation between duration of sun exposure and melasma development.

Methods: 100 patients diagnosed with melasma were included. Detailed history was taken and clinical examination done. Modified MASI score was calculated. Patients were divided into four groups depending on hours of sun exposure. Data was collected in a proforma, tabulated and analyzed.

Results: F: M ratio was 3.54:1 with 78% females and 22% males. 46% of females were in 4th decade and 72% of males were in their third decade. 35% of females were in 21-30 years age. Third decade was the commonest age of onset seen in 49% of patients. 46% patients had <1 hour and 23% had >6 hours of sun exposure per day. A p value of 0.0006 was found between the mMASI scores of group A and group D which was highly significant.

Conclusions: More number of young males with melasma in their third decade are seeking treatment. Increase in the duration of exposure to solar radiation leads to more severe melasma. So, sun exposure is a major aggravating factor. There is a need to create awareness about sun protection.

 


Keywords


Melasma, Epidemiology, Sun exposure

Full Text:

PDF

References


Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol. 1999;455:491-9.

Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin. 2007;25:343-522.

Sivayathorn A. Melasma in Orientals. Clin Drug Investig. 1995;10:24-40.

Grimes PE. Melasma: Etiologic and therapeutic considerations. Arch Dermatol. 995;131:1453-7.

Lufti RJ, Fridmanis M, Misiunas AL, Pafume O, Gonzalez EA, Villemur JA et al. Association of Melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the Melasma. J Clin Endocrinol Metab. 1985;61:28-31.

Guinot C, Cheffai S, Latreille J, Dhaoui MA, Youssef S, Jaber K et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol. 2010;24:1060-69.

Khanna N, Rasool S. Facial melanoses: Indian perspective. Indian J Dermatol Venereol Leprol. 2011;77:552-63.

Pandya AG, Hynan LH, Bhore R, Riley FC, Guevara IL, Grimes P et al. Reliability assessment and validation of the Melasma Area and Severrity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2016;64:78-83.

Walker SL, Shah M, Hubbard VG, Pradhan HM, Ghimre M. Skin disease is common in rural Nepal: results of a point prevalence study. Br J Dermatol. 2008;158:334-8.

Pawar S, Khatu S, Gokhale N. A clinico-epidemiological study of melasma in Pune patients. Pigmentary disorders. 2015; 2(11).

Krupashankar DS, Somani VK, Kohli M, Shard J, Ganjoo A, Kandhari S et al. A cross sectional, multicentric clinico-epidemiological study of melasma in India. Dermatol Ther (Heidelb). 2014;4:71-81.

Achar A, Rathi SK. Melasma: a clinic-epidemiological study of 312 cases. Indian J Derrmatol. 2011;56(4):380-2.

Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes P et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23:1254-62.